Clinical characteristics and outcomes of hospitalized patients with heart failure from the Japanese prospective registry.

IF 2.5 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Nobuyuki Enzan, Takeshi Tohyama, Tatsuya Watanabe, Takuya Nagata, Eri Noda, Yoshitomo Tsutsui, Masataka Ikeda, Takafumi Sakamoto, Shouji Matsushima, Yuya Matsue, Takeshi Kitai, Tatsunori Taniguchi, Keisuke Kida, Takahiro Okumura, Takuya Kishi, Tomomi Ide, Hiroyuki Tsutsui
{"title":"Clinical characteristics and outcomes of hospitalized patients with heart failure from the Japanese prospective registry.","authors":"Nobuyuki Enzan, Takeshi Tohyama, Tatsuya Watanabe, Takuya Nagata, Eri Noda, Yoshitomo Tsutsui, Masataka Ikeda, Takafumi Sakamoto, Shouji Matsushima, Yuya Matsue, Takeshi Kitai, Tatsunori Taniguchi, Keisuke Kida, Takahiro Okumura, Takuya Kishi, Tomomi Ide, Hiroyuki Tsutsui","doi":"10.1016/j.jjcc.2025.05.015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recent studies showed that clinical parameters other than cardiac function, such as physical function, cognitive function, mental status, social status, and quality of life, were associated with heart failure (HF) prognosis. These parameters have not been extensively investigated in large Japanese cohorts. Furthermore, novel biomarkers to predict prognosis or treatment responses are required to provide individualized medicine. To address these issues, we developed the Japanese Registry Of Acute Decompensated Heart Failure (JROADHF-NEXT).</p><p><strong>Methods: </strong>JROADHF-NEXT is a prospective, multicenter, nationwide registry of patients hospitalized for acute decompensated HF. A total of 4016 patients were enrolled from 87 centers and blood and urine samples were collected from 3203 of these patients. The study protocol using the JROADHF-NEXT database was approved by all Kyushu University, International University of Health and Welfare and participating hospitals.</p><p><strong>Results: </strong>The mean age was 72.9 ± 14.0 years and 61.4 % were male. Cardiomyopathy was the most common etiology (24.4 %). Volume overload and arrhythmia accounted for 26.3 % and 17.4 % of precipitating causes. The median follow-up period was 2.0 (1.6-2.2) years and 2-year follow-up completion rate was 88.5 % (n = 3554). The incidence rates for cardiovascular death and rehospitalization for HF were 5.2 and 16.7 per 100 person-years, respectively.</p><p><strong>Conclusions: </strong>The JROADHF-NEXT is a large-scale HF registry comprising extensive clinical variables with a biobank. This registry is anticipated to provide valuable insights and serve as a significant source of evidence for future research and clinical practice.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2025.05.015","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recent studies showed that clinical parameters other than cardiac function, such as physical function, cognitive function, mental status, social status, and quality of life, were associated with heart failure (HF) prognosis. These parameters have not been extensively investigated in large Japanese cohorts. Furthermore, novel biomarkers to predict prognosis or treatment responses are required to provide individualized medicine. To address these issues, we developed the Japanese Registry Of Acute Decompensated Heart Failure (JROADHF-NEXT).

Methods: JROADHF-NEXT is a prospective, multicenter, nationwide registry of patients hospitalized for acute decompensated HF. A total of 4016 patients were enrolled from 87 centers and blood and urine samples were collected from 3203 of these patients. The study protocol using the JROADHF-NEXT database was approved by all Kyushu University, International University of Health and Welfare and participating hospitals.

Results: The mean age was 72.9 ± 14.0 years and 61.4 % were male. Cardiomyopathy was the most common etiology (24.4 %). Volume overload and arrhythmia accounted for 26.3 % and 17.4 % of precipitating causes. The median follow-up period was 2.0 (1.6-2.2) years and 2-year follow-up completion rate was 88.5 % (n = 3554). The incidence rates for cardiovascular death and rehospitalization for HF were 5.2 and 16.7 per 100 person-years, respectively.

Conclusions: The JROADHF-NEXT is a large-scale HF registry comprising extensive clinical variables with a biobank. This registry is anticipated to provide valuable insights and serve as a significant source of evidence for future research and clinical practice.

来自日本前瞻性登记中心的住院心力衰竭患者的临床特征和结局
背景:近年来的研究表明,心功能以外的临床参数,如身体功能、认知功能、精神状态、社会地位、生活质量等与心力衰竭(HF)预后相关。这些参数尚未在大型日本队列中进行广泛调查。此外,需要新的生物标志物来预测预后或治疗反应,以提供个体化医疗。为了解决这些问题,我们开发了日本急性失代偿性心力衰竭登记处(JROADHF-NEXT)。方法:JROADHF-NEXT是一项前瞻性、多中心、全国性的急性失代偿性心衰住院患者登记研究。共有来自87个中心的4016名患者入组,其中3203名患者采集了血液和尿液样本。使用JROADHF-NEXT数据库的研究方案得到了所有九州大学、国际卫生福利大学和参与医院的批准。结果:平均年龄72.9 ± 14.0 岁,男性61.4 %。心肌病是最常见的病因(24.4% %)。容量过载和心律失常分别占26.3% %和17.4% %的诱发原因。中位随访期为2.0(1.6 ~ 2.2)年,2年随访完成率为88.5 % (n = 3554)。心衰的心血管死亡和再住院发生率分别为5.2和16.7 / 100人年。结论:JROADHF-NEXT是一个大规模的心衰登记,包括广泛的临床变量和生物库。该注册表预计将提供有价值的见解,并作为未来研究和临床实践的重要证据来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信